{"data":[{"accessionNo":"0000312069-26-000222","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDI","ticker":"RVPH","cusip":"76152G209","securityClass":"COMMON-STOCK","eventDate":"2026-06-30","reportingPerson":"Barclays PLC","reportingCik":null,"personType":"HC","sharesOwned":20,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-089899","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":1072690,"percentOfClass":8.2,"filedAt":"2026-08-03","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-089899","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1072690,"percentOfClass":8.2,"filedAt":"2026-08-03","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-089899","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1072690,"percentOfClass":8.2,"filedAt":"2026-08-03","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-089899","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1072690,"percentOfClass":8.2,"filedAt":"2026-08-03","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001610520-26-000096","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"UBS Group AG","reportingCik":null,"personType":"BK","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001649553-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"CVI Investments, Inc.","reportingCik":null,"personType":"CO","sharesOwned":672811,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001649553-26-000058","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Heights Capital Management, Inc.","reportingCik":null,"personType":"CO","sharesOwned":672811,"percentOfClass":4.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0000312069-26-000174","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDI","ticker":"RVPH","cusip":"76152G209","securityClass":"COMMON-STOCK","eventDate":"2026-03-31","reportingPerson":"Barclays PLC","reportingCik":null,"personType":"HC","sharesOwned":763579,"percentOfClass":5.96,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001610520-26-000060","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"UBS Group AG","reportingCik":null,"personType":"BK","sharesOwned":746095,"percentOfClass":5.8,"filedAt":"2026-05-07","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-036874","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-23","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":793952,"percentOfClass":6.2,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-036874","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-23","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":793952,"percentOfClass":6.2,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-036874","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-23","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":793952,"percentOfClass":6.2,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-036874","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-23","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":793952,"percentOfClass":6.2,"filedAt":"2026-03-30","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001649553-26-000036","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-18","reportingPerson":"CVI Investments, Inc.","reportingCik":null,"personType":"CO","sharesOwned":666667,"percentOfClass":5.2,"filedAt":"2026-03-25","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001649553-26-000036","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-18","reportingPerson":"Heights Capital Management, Inc.","reportingCik":null,"personType":"CO","sharesOwned":666667,"percentOfClass":5.2,"filedAt":"2026-03-25","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001493152-26-012362","formType":"SCHEDULE 13D/A","amendmentNo":13,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":"76152G209","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-20","reportingPerson":"Parag Saxena","reportingCik":"0001015823","personType":"IN","sharesOwned":363280,"percentOfClass":2.8,"filedAt":"2026-03-24","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0000921895-26-000468","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"683 CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA","sharesOwned":3492500,"percentOfClass":3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0000921895-26-000468","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Zweiman Ari","reportingCik":null,"personType":"IN","sharesOwned":3492500,"percentOfClass":3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0000921895-26-000468","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"683 CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":3492500,"percentOfClass":3,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-004596","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":3257670,"percentOfClass":2.8,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-004596","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3257670,"percentOfClass":2.8,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-004596","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Integrated Core Strategies (US) LLC","reportingCik":null,"personType":"OO","sharesOwned":3254631,"percentOfClass":2.8,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001104659-26-004596","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001742927","issuerName":"Reviva Pharmaceuticals Holdings, Inc.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3257670,"percentOfClass":2.8,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001493152-25-028783","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-18","reportingPerson":"Parag Saxena","reportingCik":"0001015823","personType":"IN","sharesOwned":6268006,"percentOfClass":5.2,"filedAt":"2025-12-22","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001493152-25-028783","formType":"SCHEDULE 13D/A","amendmentNo":12,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-18","reportingPerson":"VEDANTA PARTNERS, LLC","reportingCik":"0001502216","personType":"OO","sharesOwned":5367069,"percentOfClass":4.4,"filedAt":"2025-12-22","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0000921895-25-002634","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-22","reportingPerson":"683 CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA","sharesOwned":5435000,"percentOfClass":5.36,"filedAt":"2025-09-29","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0000921895-25-002634","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-22","reportingPerson":"683 CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":5435000,"percentOfClass":5.36,"filedAt":"2025-09-29","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0000921895-25-002634","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-22","reportingPerson":"Zweiman Ari","reportingCik":null,"personType":"IN","sharesOwned":5435000,"percentOfClass":5.36,"filedAt":"2025-09-29","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001493152-25-014806","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-22","reportingPerson":"Parag Saxena","reportingCik":"0001015823","personType":"IN","sharesOwned":6259806,"percentOfClass":6.2,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001493152-25-014806","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-09-22","reportingPerson":"VEDANTA PARTNERS, LLC","reportingCik":"0001502216","personType":"OO","sharesOwned":5367069,"percentOfClass":5.4,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"},{"accessionNo":"0001437749-25-029807","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0001742927","issuerName":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","ticker":"RVPH","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-22","reportingPerson":"Bhat Laxminarayan","reportingCik":"0001818245","personType":"IN","sharesOwned":3680874,"percentOfClass":3.8,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/rvph"}],"updatedAt":"2026-11-03T20:29:20.958Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rvph","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}